Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 1,218 | 80 | 1,130 |
| Samples | 372 | 39 | 328 |
| Peptides | 307 | 31 | 276 |
Function
STAT1 · Signal transducer and activator of transcription 1
The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. The protein encoded by this gene can be activated by various ligands including interferon-alpha, interferon-gamma, EGF, PDGF and IL6. This protein mediates the expression of a variety of genes, which is thought to be important for cell viability in response to different cell stimuli and pathogens. The protein plays an important role in immune responses to viral, fungal and mycobacterial pathogens. Mutations in this gene are associated with Immunodeficiency 31B, 31A, and 31C. [provided by RefSeq, Jun 2020].
Isoforms & Proteins
6 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 282 amino-acid changes on canonical ENST00000361099 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in STAT1 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in STAT1 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Endometrial Carcinoma | 5/42 12% | 26/612 4% |
| T-Cell Non-Hodgkins Lymphoma | 1/26 4% | 0/0 0% |
| Colorectal Carcinoma | 10/143 7% | 61/3239 2% |
| Bladder Carcinoma | 2/58 3% | 16/956 2% |
| Melanoma | 2/210 1% | 35/1899 2% |
| Non-Small Cell Lung Carcinoma | 7/304 2% | 16/1390 1% |
| Cervical Carcinoma | 0/35 0% | 6/422 1% |
| Gastric Carcinoma | 0/74 0% | 23/1809 1% |
| Esophageal Carcinoma | 0/23 0% | 9/769 1% |
| Hepatocellular Carcinoma | 0/46 0% | 21/2210 1% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 8/810 1% |
| Other Sarcomas | 0/69 0% | 7/699 1% |
| Other Solid Cancers | 0/94 0% | 12/1515 1% |
| Head and Neck Carcinoma | 2/85 2% | 10/1574 1% |
| Glioma | 0/52 0% | 14/2127 1% |
| Kidney Carcinoma | 0/85 0% | 11/1862 1% |
| Small Cell Lung Carcinoma | 2/9 22% | 2/752 0% |
| Medulloblastoma | 0/0 0% | 2/450 0% |
| Burkitts Lymphoma | 0/32 0% | 1/196 1% |
| Non-Cancerous | 0/104 0% | 4/830 0% |
| Esophageal Squamous Cell Carcinoma | 0/51 0% | 11/2550 0% |
| Biliary Tract Carcinoma | 0/54 0% | 4/950 0% |
| Meningioma | 0/3 0% | 1/252 0% |
| B-Cell Non-Hodgkins Lymphoma | 0/88 0% | 10/2534 0% |
| Ovarian Carcinoma | 1/109 1% | 3/998 0% |
| Breast Carcinoma | 4/144 3% | 6/3264 0% |
| Neuroendocrine Tumour | 1/154 1% | 1/577 0% |
| Prostate Carcinoma | 0/13 0% | 5/2105 0% |
| Neuroblastoma | 2/87 2% | 1/1331 0% |
| Pancreatic Carcinoma | 0/89 0% | 3/1611 0% |
Mutation Distribution
Where STAT1 is mutated · all tissues, split by cell line vs tissue
How many mutations in STAT1 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 1,218 mutations in STAT1
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|